Compare Marvell Technology Inc (MRVL) vs Stryker Corporation (SYK) Price & Performance

Marvell Technology (MRVL) trades at $225.41, up 0.83% with strong technical momentum and bullish analyst sentiment. The stock shows robust revenue growth projections, with management forecasting $12 billion for fiscal 2026 and $18 billion for 2027. Despite negative net income in recent periods, the company has consistently beaten EPS expectations and maintains strong profitability margins. Technical indicators show bullish moving averages with support at $221 and resistance at $231.

Marvell presents significant growth potential driven by AI chip demand, with an 82% analyst buy rating and $303 consensus price target representing 34% upside. Key risks include intense competition from Broadcom, customer concentration, and high valuation multiples. The October Investor Day could serve as a catalyst for further price appreciation if growth projections are reaffirmed.

Stryker (SYK) is trading at $276.43, down 8.81% over 24 hours, with a bearish technical signal from moving averages but bullish oscillators. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Strong fundamentals include a net income margin of 14.43% and ROE of 16.51%, though valuation ratios like a P/E of 28.65 are elevated. Recent news includes a securities fraud investigation announcement and the launch of an FDA-cleared surgical app for Apple Vision Pro.

The outlook for SYK is supported by solid profitability and growth initiatives like acquisitions and product launches, but near-term risks include the fraud investigation and competitive pressures. Analyst consensus is strongly bullish with a $376 price target, suggesting significant upside potential if the company navigates current challenges successfully.